Should You Sell Novo Nordisk A/S (NVO) Stock Friday Morning?

Novo Nordisk A/S (NVO) has fallen Friday morning, with the stock falling -2.30% in pre-market trading to 99.5. NVO's short-term technical score of 97 indicates that the stock has traded more bullishly over the last month than 97% of stocks on the market. In the Biotechnology industry, which ranks 122 out of 146 industries, Novo Nordisk A/S ranks higher than 97% of stocks. Novo Nordisk A/S has risen 5.46% over the past month, closing at $98.17 on November 3. During this period of time, the stock fell as low as $96.43 and as high as $105.69. NVO has an average analyst recommendation of Strong Buy. The company has an average price target of $115.10.

NVO has an Overall Score of 79. Find out what this means to you and get the rest of the rankings on NVO!

See Full NVO Report

Novo Nordisk A/S has a Long-Term Technical rank of 84. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 16% of the market scoring higher. In the Biotechnology industry which is number 126 by this metric, NVO ranks better than 126% of stocks.

Important Dates for Investors in NVO:

-Novo Nordisk A/S is set to release earnings on 2024-01-31. Over the last 12 months, the company has reported EPS of $20.98. -We do not have a set dividend date for Novo Nordisk A/S at this time. Click Here To Get The Full Report on Novo Nordisk A/S (NVO)